| Cisplatin | Approved Investigational | GABPB1-AS1 | 100129387 |
upregulated | Cisplatin results in increased stability of and results in increased expression of GABPB1-AS1 mRNA | 15q21.2 | |
| Cisplatin | Approved Investigational | GADD45A | 1647 |
upregulated | Cisplatin results in increased expression of GADD45A mRNA | 1p31.3 | |
| Cisplatin | Approved Investigational | GALNT16 | 57452 |
downregulated | Cisplatin results in decreased expression of GALNT16 mRNA | 14q24.1 | |
| Cisplatin | Approved Investigational | GARS | 2617 |
upregulated | Cisplatin results in increased expression of GARS mRNA | 7p14.3 | |
| Cisplatin | Approved Investigational | GBE1 | 2632 |
upregulated | Cisplatin results in increased expression of GBE1 mRNA | 3p12.2 | |
| Cisplatin | Approved Investigational | GCC1 | 79571 |
upregulated | Cisplatin results in increased expression of GCC1 mRNA | 7q32.1 | |
| Cisplatin | Approved Investigational | GCH1 | 2643 |
downregulated | Cisplatin results in decreased expression of GCH1 mRNA | 14q22.2 | |
| Cisplatin | Approved Investigational | GCLC | 2729 |
downregulated | Cisplatin results in decreased expression of GCLC mRNA | 6p12.1 | |
| Cisplatin | Approved Investigational | GCLM | 2730 |
upregulated | Cisplatin results in increased expression of GCLM mRNA | 1p22.1 | |
| Cisplatin | Approved Investigational | GDF15 | 9518 |
upregulated | Cisplatin results in increased expression of GDF15 mRNA | 19p13.11 | |
| Cisplatin | Approved Investigational | GFPT1 | 2673 |
upregulated | Cisplatin results in increased expression of GFPT1 mRNA | 2p13.3 | |
| Cisplatin | Approved Investigational | GFPT2 | 9945 |
downregulated | Cisplatin results in decreased expression of GFPT2 mRNA | 5q35.3 | |
| Cisplatin | Approved Investigational | GLI3 | 2737 |
downregulated | Cisplatin results in decreased expression of GLI3 mRNA | 7p14.1 | |
| Cisplatin | Approved Investigational | GLOD4 | 51031 |
downregulated | Cisplatin results in decreased expression of GLOD4 mRNA | 17p13.3 | |
| Cisplatin | Approved Investigational | GLS | 2744 |
upregulated | Cisplatin results in increased expression of GLS mRNA | 2q32.2 | |
| Cisplatin | Approved Investigational | GMDS | 2762 |
downregulated | Cisplatin results in decreased expression of GMDS mRNA | 6p25.3 | |
| Cisplatin | Approved Investigational | GNB1L | 54584 |
downregulated | Cisplatin results in decreased expression of GNB1L mRNA | 22q11.21 | |
| Cisplatin | Approved Investigational | GOLIM4 | 27333 |
downregulated | Cisplatin results in decreased expression of GOLIM4 mRNA | 3q26.2 | |
| Cisplatin | Approved Investigational | GORASP1 | 64689 |
upregulated | Cisplatin results in increased expression of GORASP1 mRNA | 3p22.2 | |
| Cisplatin | Approved Investigational | GOT1 | 2805 |
upregulated | Cisplatin results in increased expression of GOT1 mRNA | 10q24.2 | |
| Cisplatin | Approved Investigational | GP1BB | 2812 |
upregulated | Cisplatin results in increased expression of GP1BB mRNA | 22q11.21 | |
| Cisplatin | Approved Investigational | GPAT3 | 84803 |
upregulated | Cisplatin results in increased expression of GPAT3 mRNA | 4q21.23 | |
| Cisplatin | Approved Investigational | GPHN | 10243 |
downregulated | Cisplatin results in decreased expression of GPHN mRNA | 14q23.3 | |
| Cisplatin | Approved Investigational | GPNMB | 10457 |
downregulated | Cisplatin results in decreased expression of GPNMB mRNA | 7p15.3 | |
| Cisplatin | Approved Investigational | GPR20 | 2843 |
upregulated | Cisplatin results in increased expression of GPR20 mRNA | 8q24.3 | |